Genetic variants in epigenetic pathways and risks of multiple cancers in the game-on consortium

Reka Toth, Dominique Scherer, Linda E. Kelemen, Angela Risch, Aditi Hazra, Yesilda Balavarca, Jean Pierre J. Issa, Victor Moreno, Rosalind A. Eeles, Shuji Ogino, Xifeng Wu, Yuanqing Ye, Rayjean J. Hung, Ellen L. Goode, Cornelia M. Ulrich

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Background: Epigenetic disturbances are crucial in cancer initiation, potentially with pleiotropic effects, and may be influenced by the genetic background. Methods: In a subsets (ASSET) meta-analytic approach, we investigated associations of genetic variants related to epigenetic mechanisms with risks of breast, lung, colorectal, ovarian and prostate carcinomas using 51,724 cases and 52,001 controls. False discovery rate-corrected P values (q values < 0.05) were considered statistically significant. Results: Among 162,887 imputed or genotyped variants in 555 candidate genes, SNPs in eight genes were associated with risk of more than one cancer type. For example, variants in BABAM1were confirmed as a susceptibility locus for squamous cell lung, overall breast, estrogen receptor (ER)-negative breast, and overall prostate, and overall serous ovarian cancer; the most significant variant was rs4808076 [OR=1.14; 95% confidence interval (CI)=1.10-1.19; q = 6.87 10-5]. DPF1 rs12611084 was inversely associated with ER-negative breast, endometrioid ovarian, and overall and aggressive prostate cancer risk (OR = 0.93; 95% CI = 0.91-0.96; q = 0.005). Variants in L3MBTL3 were associated with colorectal, overall breast, ER-negative breast, clear cell ovarian, and overall and aggressive prostate cancer risk (e.g., rs9388766: OR=1.06; 95% CI=1.03-1.08; q=0.02). Variants in TET2 were significantly associated with overall breast, overall prostate, overall ovarian, and endometrioid ovarian cancer risk, with rs62331150 showing bidirectional effects. Analyses of subpathways did not reveal gene subsets that contributed disproportionately to susceptibility. Conclusions: Functional and correlative studies are now needed to elucidate the potential links between germline genotype, epigenetic function, and cancer etiology. Impact: This approach provides novel insight into possible pleiotropic effects of genes involved in epigenetic processes.

Original languageEnglish (US)
Pages (from-to)816-825
Number of pages10
JournalCancer Epidemiology Biomarkers and Prevention
Volume26
Issue number6
DOIs
StatePublished - Jun 1 2017

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Fingerprint Dive into the research topics of 'Genetic variants in epigenetic pathways and risks of multiple cancers in the game-on consortium'. Together they form a unique fingerprint.

  • Cite this

    Toth, R., Scherer, D., Kelemen, L. E., Risch, A., Hazra, A., Balavarca, Y., Issa, J. P. J., Moreno, V., Eeles, R. A., Ogino, S., Wu, X., Ye, Y., Hung, R. J., Goode, E. L., & Ulrich, C. M. (2017). Genetic variants in epigenetic pathways and risks of multiple cancers in the game-on consortium. Cancer Epidemiology Biomarkers and Prevention, 26(6), 816-825. https://doi.org/10.1158/1055-9965.EPI-16-0728